Track topics on Twitter Track topics that are important to you
Synpromics 12th in the Deloitte UK Technology Fast 50 Edinburgh, UK, 16th November 2018 / Sciad Newswire / Synpromics, the leader in gene control, is delighted to announce that it has been ranked 12...
Edinburgh, UK, 5th December 2018 / Sciad Newswire / Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, ...
Edinburgh, UK, 3rd May 2018 / Sciad Newswire / Synpromics Ltd, the leader in gene control, today announced it has been awarded a £1.9m research and development grant from Scottish Enterprise. The f...
Update (06/12/2018): uniQure has incorporated Synpromics’ strong liver promoter into a preclinical gene therapy candidate for treating hemophilia A. Published on 08/10/2018 Synpromics and uniQur...
Synpromics is pleased to announce positive data presented today by a key partner, uniQure (NASDAQ:QURE), at the European Society of Gene and Cell Therapy conference in Laus...
Synpromics is today unveiling its novel drug-regulatable promoter platform at the European Society of Cell and Gene Therapy (ESGCT) congress in Lausanne, Switzerland. The c...
Edinburgh, UK, 22nd June 2018 / Sciad Newswire / Synpromics, the leader in gene control, is delighted to announce that David Venables, CEO of the Company, has won the ‘Disruptor’ category of Sco...
Synpromics is a private company focused on commercialising its proprietary technology in the emerging field of synthetic biology by developing customised synthetic promoters. The ...
Synpromics is the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelli...
We have published hundreds of Synpromics news stories on BioPortfolio along with dozens of Synpromics Clinical Trials and PubMed Articles about Synpromics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synpromics Companies in our database. You can also find out about relevant Synpromics Drugs and Medications on this site too.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...